Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (5889)	3/13/2002 1:03:11 AM
From: scaram(o)uche	Respond to of 52153

Chuckle. Cute! I was recently asked here about my impression of Sepracor, or Sepracor came up in some context. I said that I didn't follow it. I want to emphasize, however, that I saw the company as a timely investment and that it was a 2% component of "2000", a portfolio that I maintain here at SI. Everything looked on track to me, and I should have said that I don't follow it closely. Assessment of the company here at SI looked to be top notch to me. "Biotechnology investing is not for sissies" Susan E. Atkins, President & CEO Susan E. Atkins & Associates

To: Jibacoa who wrote (5889)	3/13/2002 2:36:09 PM
From: Biomaven	Read Replies (1) \| Respond to of 52153

The third applicant stepped forward and said, "I was an HMO manager. I helped people get cost-effective health care." St.Peter said, "You can come in too." As the HMO manager walked by, St. Peter added, "You can only stay two days. After that, you can go to Hell." I think I have a revised version: The third applicant stepped forward and said, "I was an FDA regulator. I helped protect the public against dangerous and ineffective drugs." St.Peter laughed and laughed and laughed. "Maybe you did good work, but considering how much fun you had torturing biotech investors, I think you'd be a much better fit down in hell. You can always resubmit your application after a few hundred years of additional trials, though." Peter